Product Information
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2019 per ML under NDC 31722001647. Its NADAC has been published 202 times since Nov 23, 2022.
FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/5mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722001647
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA213698FDA Approved
7/5/2022
TE Code
AA
On Market Since
7/5/2022
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 202 times since Nov 23, 2022, and over the history we have for it it has declined 60.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2019 per ML |
|---|---|
| All-time high | $0.5597 (Mar 15, 2023) |
| All-time low | $0.1689 (May 20, 2026) |
| 52-week high | $0.2559 |
| 52-week low | $0.1689 |
| Median price | $0.3555 |
| Average price | $0.3612 |
| Largest weekly change | +40.9% (Nov 20, 2024) |
| Weeks tracked | 202 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Camber Pharmaceuticals Inc., is $0.2019 per ML (NDC 31722001647), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 60.2%. It has been tracked across 202 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
Since Nov 23, 2022, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.5597 (Mar 15, 2023), with a median of $0.3555 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 31722001647) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.